Platelet BioGenesis
Chestnut Hill, US · Founded 2014 · Delaware corporation · 3 known investors
Biotech
Founders & leadership
Platelet BioGenesis was founded in 2014 by Joseph Italiano and Jonathan Thon.
JI
Joseph ItalianoCo-founder
JT
Jonathan ThonCo-founder
SE
Sven Erik KarlssonExecutive
PF
Peter FinnExecutive
Investors · 3
Reported raises · per SEC filings
Form D private placements$72.9M disclosed across 4 rounds · 2016–2021
▶$35.4MraisedNov 2021 · 7 investors · OtherRule 506(b)
▶$35.4MraisedNov 2021 · 7 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Mark McDadeDirector
- Steven AltschulerDirector
- Sam RastyExecutive Officer, Director
- Chidozie UgwumbaDirector
- Philip ReillyDirector
- Richard MurrayDirector
- Joseph ItalianoDirector
- Offering amount
- $35.4M
- Amount sold
- $35.4M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$26.4MraisedAug 2019 · 34 investors · OtherRule 506(b)
▶$26.4MraisedAug 2019 · 34 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Sam RastyDirector, Executive Officer
- Steve AltschulerDirector
- Philip ReillyDirector
- Richard MurrayDirector
- Mark McDadeDirector
- Joseph ItalianoDirector
- Sven KarlssonExecutive Officer, Director
- Offering amount
- $26.4M
- Amount sold
- $26.4M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$10MraisedMay 2017 · 32 investors · BiotechnologyRule 506(b)
▶$10MraisedMay 2017 · 32 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter FinnExecutive Officer
- Jonathan ThonExecutive Officer, Director
- Philip ReillyDirector
- Joseph ItalianoDirector
- Sven KarlssonExecutive Officer, Director
- Mark McDadeDirector
- Offering amount
- $10M
- Amount sold
- $10M
- Minimum investment
- $10K
- Proceeds to insiders
- $600K
- First sale
- May 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$1.1MraisedJul 2016 · 33 investors · BiotechnologyRule 506(b)
▶$1.1MraisedJul 2016 · 33 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph ItalianoDirector
- Jonathan ThonDirector
- Sven Erik KarlssonExecutive Officer
- Peter FinnExecutive Officer
- Offering amount
- $1.5M
- Amount sold
- $1.1M
- Minimum investment
- $5K
- Proceeds to insiders
- $400K
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $600K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $50K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who founded Platelet BioGenesis?
- Platelet BioGenesis was founded by Joseph Italiano, Jonathan Thon in 2014.
- Who are Platelet BioGenesis's investors?
- Platelet BioGenesis's investors include Boston Harbor Angels, Qiming Healthcare, Third Rock Ventures.
- How much funding has Platelet BioGenesis raised?
- Platelet BioGenesis has disclosed $72.9M raised across 4 rounds.
- Where is Platelet BioGenesis headquartered?
- Platelet BioGenesis is headquartered in Chestnut Hill, US.